Rep. Val T. Hoyle Sells Kenvue Inc. (NYSE:KVUE) Shares

Key Points

• Representative Val T. Hoyle sold shares of Kenvue Inc. (NYSE:KVUE) valued between $1,001 and $15,000 on September 23rd, which was disclosed in a filing on October 10th.
• Kenvue's stock is currently down 1.0%, trading at $16.68, with a market capitalization of $32 billion and a 52-week high of $25.17.
• The company recently increased its quarterly dividend to $0.2075, yielding 5.0% annually, and reported earnings per share of $0.29 for the last quarter.

Representative Val T. Hoyle (D-Oregon) recently sold shares of Kenvue Inc. NYSE: KVUE. In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on September 23rd. The trade occurred in the Representative's "FIDELITY ROLLOVER IRA" account.

Representative Val T. Hoyle also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Marriott International NASDAQ: MAR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Transdigm Group NYSE: TDG on 9/23/2025.
• Sold $1,001 - $15,000 in shares of H&R Block NYSE: HRB on 9/23/2025.
• Sold $1,001 - $15,000 in shares of NIKE NYSE: NKE on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Bank of New York Mellon NYSE: BK on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Cisco Systems NASDAQ: CSCO on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Capital One Financial NYSE: COF on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Pentair NYSE: PNR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Heico NYSE: HEI.A on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Target NYSE: TGT on 9/23/2025.

Kenvue Stock Down 1.0%

Shares of NYSE KVUE traded down $0.17 during midday trading on Friday, reaching $16.68. The company's stock had a trading volume of 21,091,284 shares, compared to its average volume of 38,541,960. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a fifty-two week low of $15.47 and a fifty-two week high of $25.17. The stock has a market capitalization of $32.00 billion, a price-to-earnings ratio of 22.53, a PEG ratio of 2.42 and a beta of 0.72. The stock has a 50 day simple moving average of $19.15 and a 200-day simple moving average of $21.34.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The company had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same period last year, the company earned $0.32 earnings per share. The firm's revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were issued a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.0%. This is a boost from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. Kenvue's dividend payout ratio is 112.16%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Rothschild & Co Redburn raised shares of Kenvue from a "neutral" rating to a "buy" rating and decreased their target price for the company from $22.50 to $22.00 in a research note on Friday, September 26th. JPMorgan Chase & Co. decreased their target price on shares of Kenvue from $24.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday. Zacks Research raised shares of Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Redburn Partners set a $22.00 target price on shares of Kenvue in a research note on Friday, September 26th. Finally, The Goldman Sachs Group reduced their price objective on shares of Kenvue from $22.00 to $19.00 and set a "neutral" rating for the company in a research report on Thursday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Kenvue currently has a consensus rating of "Hold" and a consensus target price of $21.18.

Institutional Investors Weigh In On Kenvue

Several institutional investors and hedge funds have recently bought and sold shares of KVUE. Pittenger & Anderson Inc. bought a new stake in Kenvue during the first quarter worth about $30,000. Trust Co. of Vermont raised its stake in Kenvue by 266.8% during the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company's stock worth $33,000 after acquiring an additional 1,150 shares in the last quarter. TruNorth Capital Management LLC acquired a new position in Kenvue during the first quarter worth about $36,000. Truvestments Capital LLC acquired a new position in Kenvue during the first quarter worth about $37,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its stake in Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock worth $39,000 after acquiring an additional 1,287 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

About Representative Hoyle

Val Hoyle (Democratic Party) is a member of the U.S. House, representing Oregon's 4th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. Hoyle (Democratic Party) is running for re-election to the U.S. House to represent Oregon's 4th Congressional District. She declared candidacy for the 2026 election. Val Hoyle was born in California and lives in Springfield, Oregon. Hoyle graduated from Merrimack High School. She earned a B.A. in political science from Emmanuel College in 1992. Her career experience includes working as a director at United Way of Lane County, a policy fellow at Wayne Morse Center for Law and Politics, and a commissioner at the Oregon Bureau of Labor and Industries. Hoyle has also worked in domestic and international sales, as well as manufacturing distribution.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.